Catalyst Awardees

Learn more about the Catalyst Award for the Development of Diagnostics, Devices, Therapeutics and Digital Health

Spring 2014

  • Scott Baraban, PhD Zebrafish as a Model for Drug Discovery in Epilepsy
  • Charles Chiu, MD, PhD Clinical Validation of a Multiplexed Diagnostic Assay for Lyme Disease and Other Tickborne Illnesses During Acute Infection
  • Ellyn Cohen, PhD Development of a Mobile Application for Increasing Access to UCSF Clinical Trials
  • Pamela England, PhD Small Molecules Targeting Parkinson’s Disease
  • Ron Keizer, PhD Cloud-Based Dose-Individualization of Busulfan in Children
  • Marc Levin, MD, PhD Small Molecule Therapy for Dry Eye Therapy
  • Michael Matthay, MD Mesenchymal Stem Cell Derived Biologics for Treatment of Acute Respiratory Distress Syndrome
  • Catherine Park, MD A Real-Time Intraoperative Fluorescent Imager for Microscopic Residual Tumor
  • Lei Stanley Qi A Novel Epigenetic Therapeutic Strategy For Treating Beta-Thalassemia
  • Rebecca Sudore, MD A Novel Website to Preparing Diverse Older Adults for Medical Decision Making

Back to top

Fall 2013

Back to top

Spring 2013

Back to top

Fall 2012

  • Adam Abate PhD Detection and molecular profiling of cancer cells with Megadroplet Arrays
  • Nancy Boudreau PhD Topical HoxA5 gene therapy for Squamous Cell Carcinoma
  • Jonah Chan PhD A Binary Indicant of Myelination using Micropillar Arrays: A high-throughput screening platform for identifying remyelination therapeutics for Multiple Sclerosis
  • Michael Conte MD Pro-Resolving Vascular Devices
  • Brian Feeley MD Affordable 3-Dimensional Motion Analysis to Evaluate Lower Extremity Injury Risk
  • John Gross PhD Inhibition of HIV infectivity by targeting the Ubiquitin Proteasome System
  • Michael Harrison MD Amnioseal: Preventing premature birth in fetal intervention
  • Roberta Keller MD Antenatal sildenafil to prevent neonatal pulmonary hypertension in severe fetal diaphragmatic hernia
  • Ngoc Ly MPH, MD Promoting Asthma Self-Management through an Interactive AsthmaMD Mobile App
  • Mary Nakamura MD A Recombinant Fusion Protein that redirects VEGF to actively kill cancer cells: R1FasL
  • Yong Pang PhD Quantitative Assessment of Liver Fat using Fast MR Imaging and 8-Channel Microstrip Coil Array
  • Catherine Park MD Development of a Real-Time Intraoperative Fluorescent Imager for Microscopic Residual Tumor
  • Anand Patel MD Intravenous Chemotherapy Filter: A Novel Device for High Dose Chemotherapy Delivery During Transarterial Chemoembolization
  • Jayant Rajan MD Estimation of the prevalence of chronic disease in an urban slum population in Brazil using a mobile computing platform
  • Shuvo Roy PhD Enabling the Feasibility Demonstration of a Bioartificial Pancreas
  • Marshall Stoller MD, Herman Bagga MD, and Aenor Sawyer MD A Novel Device to Promote Ambulation of the Hospitalized Patient
  • Naomi Stotland MD Pregnancy Weight Gain Coach—A Smartphone App
  • Leslee Subak MD Novel mHealth app and embedded platforms (wearable devices) for urinary incontinence treatment and research
  • Francis Szoka PhD Oral and Pulmonary Delivery of Proteins
  • Lili Zhou PhD Novel strategies to predict and enhance the activity of natural killer cells against Multiple Myeloma

Back to top

Spring 2012

  • Conor Caffrey PhD Developing a new chemotherapeutic for treatment of the neglected tropical disease, schistosomiasis
  • John Chorba MD Targeting the serine protease PCSK9 via covalent complementarity
  • Charles Craik PhD Validation of KSHV protease as a therapeutic target through allosteric inhibition
  • Tejal Desai PhD Nanoengineered thin film devices for ocular drug delivery
  • John Fahy MD Modified carbohydrate derivatives as novel reducing agents for the treatment of pathologic mucus in acute and chronic airway disease.
  • Ari Green MD Retinal imaging of amyloid-beta as a screening tool for glaucoma and Alzheimer's disease.
  • Wolfgang Korn MD Development of a predictive marker for sensitivity to treatment with MEK and EGFR
  • Peder Larson PhD Simultaneous Perfusion and metabolic imaging in a prostate cancer
  • Robin Shaw MD, PhD A novel biomarker for heart failure based on cardiomyocyte biology
  • Jay Stewart MD A novel photodynamic therapy for the treatment of infectious keratitis
  • Ashley Ward MD Targeting hyperactive Ras with kinase inhibitors in juvenile myelomonocytic

Back to top

Fall 2011

  • Adam Abate PhD Robust detection and genotyping of rare circulating tumor cells in human blood
  • Christopher Barnett MD, MPH Evaluation of the acute hemodynamic effects of dark chocolate in patients with WHO Group I pulmonary arterial hypertension
  • Aditi Bhargava PhD Targeted delivery of RNAi molecules for treatment of neuronal pathophysiologies
  • Hobart Harris MD Prevention of incisional hernias
  • Michael Matthay MD Allogeneic human mesenchymal stem cells for the treatment of human acute lung injury
  • Synthia Mellon PhD Neurosteroids as therapeutics for brain disorders
  • Robert Messing MD Discovery of a PKC epsilon-selective inhibitor to treat pain
  • Mary Nakamura MD Recombinant fusion proteins that redirect VEGF to actively kill cancer cells: R1FasL and R1TRAIL
  • Douglas Nixon MD, PhD Herv antibodies and breast cancer
  • Mark Wilson MD Catheter-directed tissue ablation in the interventional MRI environment
  • Yvonne Wu MD, MPH Neonatal erythropoietin in asphyxiated term infants
  • Iwei Yeh MD, PhD Droplet digital PCR detection of circulating melanoma DNA—detecting early metastasis and progression in the age of targeted therapy

Back to top

Spring 2011

  • Adam Gazzaley MD, PhD Development of integrated physical and cognitive therapeutic software
  • Lily Jan PhD Novel blockers of TMEM16A-CaCC calcium-activated chloride channels for asthma treatment
  • Jay Nadel MD Use of EGFR inhibitors in the treatment of respiratory viral infections including virus-induced asthma exacerbations
  • Douglas Nixon MD, PhD A monoclonal antibody to cure HIV-1 infection
  • Michael Page PhD In vivo diagnostics for cardiovascular disease
  • Paul Simpson MD Treatment of cardiomyopathy and heart failure
  • Louise Swainson PhD The use of synthetic peptidoglycan-peptide conjugates for the induction of antigen-specific tolerance in autoimmune disease

Back to top

Fall 2010

  • Anthony Luke MD Validation of the RunSafe: 2-Dimensional gait analysis method with gold standard 3-Dimensional biomechanical analysis
  • Daniel Schwartz MD Use of phase contrast OCT for imaging the human retinal vasculature
  • Qizhi Tang PhD Manufacturing donor-specific regulatory T cells

Back to top

Spring 2010

Back to top